trb_welcome.jpg

 

The mission of TRB Chemedica Group is to develop innovative and patented pharmaceutical products and medical devices in niche therapeutic areas: rheumatology, ophthalmology and neurology.


New VISMED® MULTI preservative-free multidose dispenser

TRB Chemedica announces the launch of the new VISMED® MULTI fitted with the innovative and patented preservative-free multidose Ophthalmic Squeeze Dispenser (OSD) for the treatment of dry eye.

Dry eye patients instil regularly lubricant eye drops, and often for the rest of their life. Most of these patients are elderly and experience difficulties when using preservative-free multidose dispensers, since dispensing systems currently available do not offer overall satisfaction for eye drop delivery.

The OSD squeezable dispenser -the result of more than 10 years of development for the delivery of preservative-free ophthalmic solutions- highlights the following features :
    1) intrinsic intuitiveness of a squeezable container,
    2) user friendliness for all adult age groups due to a low actuation force,
    3) precise and reproducible drop ejection,
    4) ergonomic and pocket size design.

The new VISMED® MULTI, a patented, sterile, hypotonic lubricant eye drops formulation of 0.18 % hyaluronic acid with essential ions calcium, magnesium and potassium, contains 10 ml of solution, equivalent to more than 250 drops and remains sterile for up to 3 months after first use. The worldwide trend to use safe, patient-friendly, cost-effective and preservative-free multidose dispensers such as the OSD system underlines VISMED® MULTI commitment to maintain its status as the gold standard in lubricant eye drops.  

packshot_vismedmulti_combi_rgb_72dpi.jpg

 


ostenil_plus.png

Mannitol-stabilised high dose HA for sustained effect

OSTENIL® PLUS is a unique combination of natural high dose HA (2%) + mannitol.

Mannitol acts as a free radical scavenger which protects HA from rapid depolymerisation.

The formulation offers the possibility of reducing the number of intra-articular injections and increasing the intervals between injections. 

OSTENIL® PLUS reduces pain and improves function in osteoarthritis with very good tolerability.

Effective treatment with 1 to 3 injections of OSTENIL® PLUS

ostenil_plus.jpg
This new packaging design may not yet be available in your country 


pdf OSTENIL® PLUS Brochure
pdf OSTENIL® Line Brochure
pdf OSTENIL® PLUS instructions for use
Distributors
trb_contact.gifContacts

News-Events
 
 
  • English